Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunitybio Inc (NQ: IBRX ) 4.150 -0.040 (-0.95%) Streaming Delayed Price Updated: 11:59 AM EDT, Aug 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 519,867 Open 4.180 Bid (Size) 4.150 (7) Ask (Size) 4.160 (14) Prev. Close 4.190 Today's Range 4.090 - 4.250 52wk Range 1.250 - 10.53 Shares Outstanding 391,156,513 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 19, 2024 Via Benzinga Top 3 Health Care Stocks That Are Set To Fly This Quarter August 16, 2024 Via Benzinga Performance YTD -20.80% -20.80% 1 Month -23.57% -23.57% 3 Month -37.31% -37.31% 6 Month -9.58% -9.58% 1 Year +151.52% +151.52% More News Read More 9 Health Care Stocks Whale Activity In Today's Session August 13, 2024 Via Benzinga IBRX Stock Earnings: ImmunityBio Misses EPS, Misses Revenue for Q2 2024 August 12, 2024 Via InvestorPlace How Is The Market Feeling About ImmunityBio? May 17, 2024 Via Benzinga ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval August 12, 2024 From ImmunityBio, Inc. Via Business Wire ImmunityBio Announces Study of ANKTIVA® in Combination with the AdHER2DC Cancer Vaccine as a Potential Therapy to Control Endometrial Cancer August 06, 2024 From ImmunityBio, Inc. Via Business Wire IMMUNITYBIO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX July 26, 2024 From Kahn Swick & Foti, LLC Via Business Wire 7 Biotech Stocks to Keep on Your Clinical Radar July 23, 2024 Via InvestorPlace 3 Top Cancer Treatment Stocks to Buy Now July 17, 2024 Via InvestorPlace China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio? June 23, 2024 Via Benzinga Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga Why ImmunityBio Stock Is Trading Higher Thursday June 20, 2024 Via Benzinga KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday June 20, 2024 Via Benzinga ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors June 20, 2024 From ImmunityBio, Inc. Via Business Wire 3 Short-Squeeze Stocks Outwitting the Pessimistic Predictions June 20, 2024 Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update June 07, 2024 From ImmunityBio, Inc. Via Business Wire These 3 Interesting Stocks Are Seeing Heavy Short Interest In June 2024 June 04, 2024 Via Talk Markets Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast May 17, 2024 From ImmunityBio, Inc. Via Business Wire Amid Biotech Pitfalls, ImmunityBio Has Outperformed NVDA In The Last 3 Months May 13, 2024 Via Talk Markets IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024 May 10, 2024 Via InvestorPlace The 3 Best Bargain Stocks to Buy in May 2024 May 09, 2024 Via InvestorPlace Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday May 07, 2024 Via Benzinga ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA® May 07, 2024 From ImmunityBio, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
